« Back
Home /
Aspirin DL-lysine

Aspirin DL-lysine

Item no.	TMO-T20458-1g
Manufacturer	TargetMol
CASRN	62952-06-1
Amount	1 g
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	Yasu T, Oshima S, Imanishi M, Nonogi H, Haze K, Kuramochi M, Omae T, Hayashi Y, Yamamoto S. Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris. Am J Cardiol. 1993 May 15;71(13):1164-8. PubMed PMID: 8480641.
Smiles	O=C(O)C=1C=CC=CC1OC(=O)C.O=C(O)C(N)CCCCN
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	DL-Lysine acetylsalicylic acid salt, Aspegic, ASL, Aspisol
Shipping condition	Cool pack
Available
Shipping Temperature	cool pack
Storage Conditions	-20°
Molecular Weight	326, 35
Target names or alias	ASL , Aspegic , Aspisol , DL-Lysine acetylsalicylic acid salt
Description	Aspirin DL-lysine is a non-steroidal anti-inflammatory drug. It also may inhibit cancer growth. Aspirin DL-lysine is a water-soluble, injectable aspirin derivative.
Pathways	Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T20458-1g-datasheet.pdf

TMO-T20458-1g-safety-datasheet.pdf